Home
About
Overview
Sharing Data
ORCID
Help
History (11)
First international TNBC conference meeting report.
DNA N(6)-methyladenine: a new epigenetic mark in eukaryotes?
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.
Roles of young serine-endopeptidase genes in survival and reproduction revealed rapid evolution of phenotypic effects at adult stages.
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature. 2012 Dec 06; 492(7427):118-22.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antibodies, Neutralizing
Antibody Specificity
Disease Models, Animal
Half-Life
HIV Antibodies
HIV Infections
HIV-1
Humans
Immunization, Passive
Mice
Mice, Inbred NOD
Time Factors
Viral Load
authors with profiles
Ariel Halper-Stromberg